z-logo
open-access-imgOpen Access
Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin‑resistant human epidermal growth factor receptor 2‑positive breast cancer
Author(s) -
Junjun Liu,
Hanzhi Ding,
Quan Hong,
Jing Han
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12927
Subject(s) - niclosamide , cancer research , breast cancer , cancer , cancer stem cell , epithelial–mesenchymal transition , cisplatin , biology , cell growth , metastasis , medicine , chemotherapy , ecology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom